‹ All Posts
Saksham Sharma - SEBI RIA

11th Jul · SEBI-Registered Analyst

The Complan-Glucon-D Company Just Quietly Rallied 40%+ and Almost Nobody Noticed

Ask most people what

ZYDUSWELL
makes, and they'll say Complan, Glucon-D, maybe Sugar Free. Almost nobody will tell you the stock has climbed over 40% in the past year, while the Sensex itself was roughly flat over the same period. That gap between brand recognition and market attention is worth a closer look. A few quarters ago, this company was actually posting losses. Then in Q4 FY26, it delivered its highest-ever quarterly revenue at ₹1,484.70 crore, up 62.6% year-on-year, and returned to profit with ₹162 crore in net income. Even its seasonal brands, the ones usually hit hardest by an early monsoon, still managed double-digit growth in a recent quarter — a sign the demand underneath the recovery is broad, not propped up by one hot product. There's a quieter detail too: in June 2026, the company incorporated two new subsidiaries in Dubai. It's easy to miss in a routine filing, but it signals a business confident enough in its recovery to start looking outward, not just defending its home turf. None of this means the stock is cheap — valuation multiples here are genuinely rich, so a lot of optimism is already priced in. But it's a good reminder that some of the most interesting turnarounds happen in companies whose products you already have in your kitchen cabinet, not just in flashy new-age names.

#HiddenGems#TechnicalViews#FundamentalViews#EquityResearch#MacroViews
ZydusWellness Technical and fundamental view.pdf
496 likes·62 comments